STVN — Stevanato Group S.p.A.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1849853 ·
Italy
Last close
$22.27
Market Cap
$1.11B
52W High
$23.17
52W Low
$16.27
ADV30
438,333
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 302,003,000 | 86,811,000 | 51,282,000 | 22,958,000 | 2,618,744,000 | 78,639,000 | 1,068,905,000 |
| Mar 2026 | 273,574,000 | 75,178,000 | 38,737,000 | 28,029,000 | 2,583,821,000 | 111,670,000 | 1,052,995,000 |
| Dec 2025 | 346,482,000 | 106,899,000 | 70,084,000 | 47,555,000 | 2,543,974,000 | 130,603,000 | 1,057,453,000 |
| Sep 2025 | 303,167,000 | 88,500,000 | 52,721,000 | 36,064,000 | 2,414,007,000 | 113,333,000 | 976,721,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$248,680,000
Investing CF
$-276,830,000
Financing CF
$9,806,000
CapEx
$-279,429,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$0.48
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$1,028,796,000
Inventory
$308,995,000
Receivables
$539,660,000
ST Investments
$4,941,000
EBIT TTM
$199,758,000
Pretax Income TTM
$192,206,000
Interest Exp TTM
$7,552,000
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,225,227,008
EBITDA
$298,831,008
Free Cash Flow
$-104,701,248
Enterprise Value
$6,448,713,216
Total Cash
$79,142,000
Total Debt
$445,302,016
Shares Out
49,709,718
Trailing EPS
$0.57
Book Value
$6.56
ROE
9.1%
ROA
5.4%
Div Yield
0.27%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,186,282,000 | 198,801,000 | 139,839,000 | 2,543,974,000 | 1,057,453,000 | — | 286,077,000 |
| Dec 2024 | 1,104,036,000 | 161,142,000 | 117,778,000 | 2,328,819,000 | 924,434,000 | — | 155,776,000 |
| Dec 2023 | 1,085,354,000 | 200,720,000 | 145,631,000 | 2,071,577,000 | 938,931,000 | — | 105,210,000 |
| Dec 2022 | 983,680,000 | 192,431,000 | 142,849,000 | 1,659,698,000 | 663,788,000 | — | 103,312,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.84
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $17.50 · spot: $22.27 · call volume: 20 · put volume: 10
Expected Move to 2026-09-18:
±$2.83
(12.71%) —
implied range
$19.44 –
$25.10
· ATM straddle on $22.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IRMD | IRADIMED CORP | $1.11B | $87.18 | — |
| PRCT | PROCEPT BioRobotics Corp | $1.22B | $21.25 | — |
| BVS | Bioventus Inc. | $957.64M | $14.02 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.30B | $16.69 | — |
| AORT | ARTIVION, INC. | $1.31B | $26.89 | — |
News headlines (Yahoo Finance, 1h cache)
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update
2026-08-11 02:08 · Yahoo
Stevanato (STVN) Q2 2026 Earnings Call Transcript
2026-08-05 02:41 · Yahoo
Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ...
2026-08-04 21:02 · Yahoo
Sage Park Acquires Balda C. Brewer, the California-based Contract Manufacturing Injection Molding Subsidiary From Stevanato Group S.p.A.
2026-08-04 14:00 · Yahoo
Stevanato Group (STVN) Q2 Earnings Top Estimates
2026-08-04 11:50 · Yahoo
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
2026-07-21 10:30 · Yahoo
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN)
2026-07-01 13:28 · Yahoo
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
2026-06-14 10:10 · Yahoo
How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals
2026-08-10 13:12 · Yahoo
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings
2026-08-10 11:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.